Our products

A company dedicated to orphan products in the treatment of cancers with an approach targeted on drug resistance, Onxeo designs and develops innovative drugs in rare and orphan diseases. The Company has also developed and registered two initial drugs based on its innovative Lauriad™ mucoadhesive technology which allow it to raise the efficacy or tolerance profile of an active ingredient for its chosen indication.

Orphan oncology products

Other products